Clinical trial
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis
Name
41688
Description
This is a non-surgical trial comparing the clinical and functional outcomes of patients with osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue versus conventional therapy of intra-articular injection of corticosteroid.
Trial arms
Trial start
2018-04-01
Estimated PCD
2025-01-26
Trial end
2025-03-26
Status
Active (not recruiting)
Phase
Early phase I
Treatment
Micro Fragmented Adipose Tissue
Harvesting of Micro Fragmented Adipose Tissue with intra-articular injection
Arms:
MFAT(Micro Fragmented Adipose Tissue)
Other names:
MFAT
Corticosteroid injection
Sham harvesting of adipose tissue without intra-articular injection. Intra-articular injection of corticosteroid.
Arms:
Conventional therapy
Size
40
Primary endpoint
Knee Injury and Osteoarthritis Outcomes Score (KOOS) Score
24 months
Eligibility criteria
Inclusion Criteria:
* Age between 35 and 75 years-old
* Diagnosis of pre-existing osteoarthritis of the joint by Kellgren-Lawrence Grade 2 or 3.
* Working understanding of the English language and able to fully understand the procedure
* Capable of providing informed consent
* Able to complete online, in-person or phone surveys for the purposes of follow-up
* Capable of understanding pre- and post-procedure care instructions
* Ambulatory at baseline
* Previous trial and failure of conservative therapy consisting of a minimum of 6 weeks of physical therapy and trial of anti-inflammatory medications if not contraindicated, with or without concomitant bracing and/or injections.
Exclusion Criteria:
* Age \< 35 or \> 75 years old
* Radiographs demonstrating either no, little or severe osteoarthritis (Kellgren-Lawrence Grade 0, 1 )
* Prior total or partial joint replacement surgery or a surgery involving cartilage regeneration (microfracture, ACI, etc)
* Previous cortisone and/or Hyaluronic acid intra-articular injection within the last 3 months
* Co-morbidity with rheumatologic condition, inflammatory arthritis
* Currently undergoing immunomodulatory therapy
* Uncontrolled endocrine disorder
* BMI \>35
* Current diagnosis of osteomyelitis, human immunodeficiency virus (HIV-1, -2) and/or hepatitis C (HCV), infection and poorly controlled diabetes (HgA1C \>7.0)
* Pregnancy or planned pregnancy
* previous stem cell injection into treatment joint
* Patient scheduled to undergo any concomitant surgical procedures.
* Coagulopathy or anticoagulant treatment
* Chronic pain involving multiple body parts or opioid medication management
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 40, 'type': 'ACTUAL'}}
Updated at
2023-10-06
1 organization
2 products
3 indications
Organization
Stanford UniversityIndication
OsteoarthritisIndication
KneeIndication
Knee PainProduct
Corticosteroid